Investigation of phosphoproteome in RAGE signaling

Kedar B Batkulwar1, Sneha B Bansode, Gouri V Patil

  • 1Proteomics Facility, Division of Biochemical Sciences, CSIR-National Chemical Laboratory, Pune, India.

Proteomics
|October 16, 2014
PubMed

Insights

The receptor for advanced glycation end products (RAGE) activates kinases that phosphorylate substrates, impacting diseases like cancer and diabetes. Understanding these RAGE-activated kinases and their phosphoproteome is crucial for disease research.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Disease Mechanisms

Background:

  • The receptor for advanced glycation end products (RAGE) is a key protein in diabetes, cardiovascular diseases, neurodegenerative diseases, and cancer.
  • RAGE acts as a pattern recognition receptor, interacting with multiple ligands and activating signal transduction pathways via kinases.

Purpose of the Study:

  • To review RAGE-activated kinases and their phosphoproteome in response to various ligands.
  • To analyze known kinase substrates from the PhosphoSitePlus database.
  • To discuss the role of these substrates in major diseases.

Main Methods:

  • Literature review of RAGE-activated kinases and their substrates.
  • Data mining from the PhosphoSitePlus database for kinase-substrate interactions.
  • Analysis of substrate roles in cancer, diabetes, cardiovascular, and neurodegenerative diseases.

Main Results:

  • Identified multiple RAGE-activated kinases and their associated phosphoproteome.
  • Cataloged known substrates for these kinases, highlighting their involvement in disease pathways.
  • Provided examples like glycogen synthase kinase 3 beta (GSK3B) and its role in neuronal damage.

Conclusions:

  • Understanding RAGE-activated kinases and their phosphoproteome is essential for elucidating RAGE's role in disease progression.
  • This knowledge can guide the development of targeted therapies for RAGE-mediated diseases.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

3.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.9K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K